Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Aug 16, 2025; 17(8): 109176
Published online Aug 16, 2025. doi: 10.4253/wjge.v17.i8.109176
Table 2 Special definitions and data transformations
Characteristic
Terms
Explanation
VariablesIndicationFor the purpose of this study, each colonoscopy was assigned only a single indication using a hierarchical coding system, with the following priority order: (1) Clinical symptoms; (2) FOBT (+); (3) Surveillance (previous patient); (4) Surveillance (new patient); and (5) Screening
Bowel preparation statusBoston Bowel Preparation Scores were collated into three broad groups: Inadequate (BBPS ≤ 5), adequate (BBPS 6 or 7), good (BBPS 8 or 9)
Serrated polyposis syndrome statusThis variable amalgates the distinction between those with SPS diagnosed in a previous colonscopy and those with SPS diagnosed from the present colonoscopy. It represents whether SPS classified as present or absent
Polypectomy quality indicatorsPolypectomy rateThe proportion of colonoscopies during which at least one polypectomy was performed
ADRThe proportion of colonoscopies during which at least one conventional adenomatous polyp, (tubular adenomas, tubulovillous adenomas, or villous adenomas) was detected. Excludes malignancies
ASLDRThe proportion of colonoscopies during which at least one serrated lesion was detected
SPDRThe proportion of colonoscopies during which at least one SSL/dSSL or TSA is detected. Excludes HPs
PSDR
SDR
The propotion of colonoscopies during which at least one of any serrated lesion (HP, SSL, dSSL, or TSA) is detected proximal to the border between the descending and sigmoid colon
SSL-DRThe proportion of colonoscopies during which at least one SSL, dSSL is detected